Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.10.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2018
STOCK-BASED COMPENSATION  
Schedule of stock-based compensation related to all of the entity's share-based payments

Total stock‑based compensation expense related to all of our stock‑based awards was as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

 

2018

    

2017

    

2016

 

Selling, general and administrative

 

 

$

5,383

 

$

4,490

 

$

4,230

 

Research and development

 

 

 

2,321

 

 

1,497

 

 

3,103

 

Restructuring charges

 

 

 

 —

 

 

 —

 

 

499

 

Total stock-based compensation expense

 

 

$

7,704

 

$

5,987

 

$

7,832

 

 

Summary of weighted-average assumptions relating to options granted pursuant to equity incentive plans

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

 

 

December 31,

 

 

    

    

2018

    

2017

    

2016

 

Risk-free interest rate

 

 

2.7

%  

2.2

%  

1.8

%

Expected term (in years)

 

 

6.7

 

6.6

 

6.2

 

Dividend yield

 

 

0.0

%  

0.0

%  

0.0

%

Expected volatility

 

 

65.1

%  

63.5

%  

61.1

%

 

Schedule of option activity under equity incentive plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

    

 

 

    

Weighted-

    

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

 

Shares Available

 

Number of Shares

 

Weighted-Average

 

Contractual Term

 

Aggregate

 

 

 

For Grant

 

Underlying Options

 

Exercise Price

 

(in years)

 

Intrinsic Value

 

Outstanding at January 1, 2018

 

11,696,696

 

20,408,140

 

$

5.45

 

 

 

 

 

 

Authorized for grant

 

4,878,124

 

 

 

 

 

 

 

 

 

 

Granted

 

(4,594,225)

 

4,594,225

 

$

4.19

 

 

 

 

 

 

Exercised

 

 

(1,172,615)

 

$

2.75

 

 

 

 

 

 

Cancelled

 

3,116,419

 

(3,116,419)

 

$

12.87

 

 

 

 

 

 

Outstanding at December 31, 2018

 

15,097,014

 

20,713,331

 

$

4.20

 

5.96

 

$

701,842

 

Vested and expected to vest at December 31, 2018

 

 

 

20,513,331

 

$

4.21

 

 

 

 

 

 

Exercisable at December 31, 2018

 

 

 

14,750,561

 

$

4.39

 

4.84

 

$

580,787

 

 

Schedule of stock options by exercise price

Details of our stock options by exercise price are as follows as of December 31, 2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

Options Exercisable

 

 

    

Number of

    

Weighted-Average

    

 

 

    

 

    

 

 

 

 

 

Outstanding

 

Remaining

 

Weighted-Average

 

Number of

 

Weighted-Average

 

Exercise Price

 

Options

 

Contractual Life (in years)

 

Exercise Price

 

Options

 

Exercise Price

 

$1.68 - $2.14

 

3,879,555

 

6.68

 

$

2.12

 

3,278,782

 

$

2.12

 

$2.15 - $2.76

 

3,344,004

 

6.92

 

 

2.61

 

2,756,548

 

 

2.65

 

$2.77 - $3.67

 

3,532,086

 

6.12

 

 

3.49

 

2,433,716

 

 

3.48

 

$3.68 - $4.49

 

4,893,668

 

8.79

 

 

4.25

 

1,217,498

 

 

4.10

 

$4.50 - $7.60

 

3,326,279

 

1.94

 

 

6.57

 

3,326,279

 

 

6.57

 

$7.61 - $9.80

 

1,737,739

 

1.97

 

 

8.71

 

1,737,739

 

 

8.71

 

$1.68 - $9.80

 

20,713,331

 

5.96

 

 

4.20

 

14,750,562

 

 

4.39

 

 

Summary of weighted-average assumptions used to calculate fair value of purchase rights granted under Employee Stock Purchase Plan

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

 

December 31,

 

 

    

2018

    

2017

    

2016

 

Risk-free interest rate

 

2.4

%  

0.5

%  

0.5

%

Expected term (in years)

 

1.3

 

1.5

 

1.5

 

Dividend yield

 

0.0

%  

0.0

%  

0.0

%

Expected volatility

 

66.2

%  

63.1

%  

62.9

%